THE BioMed Co., Ltd. (KOSDAQ:214610)
South Korea
· Delayed Price · Currency is KRW 5,530.00
-90.00 (-1.60%)
At close: Aug 14, 2025, 3:30 PM KST
THE BioMed Revenue
THE BioMed had revenue of 2.43B KRW in the quarter ending March 31, 2025, a decrease of -1.92%. This brings the company's revenue in the last twelve months to 4.59B, down -27.30% year-over-year. In the year 2024, THE BioMed had annual revenue of 4.64B, down -13.55%.
Revenue (ttm)
4.59B
Revenue Growth
-27.30%
P/S Ratio
10.09
Revenue / Employee
91.85M
Employees
50
Market Cap
46.35B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| HD Hyundai Heavy Industries | 15.32T |